Epigenome-Wide Association Studies (EWAS) are research approaches aimed at identifying associations between epigenetic modifications and various phenotypes or diseases. These studies focus on the epigenome, which encompasses all chemical modifications to DNA and histone proteins that regulate gene expression without altering the underlying DNA sequence. Key techniques used in EWAS include methylation profiling and chromatin accessibility assays, which allow researchers to assess how changes in the epigenome correlate with traits such as susceptibility to diseases, response to treatments, or other biological outcomes.
Unlike traditional genome-wide association studies (GWAS), which investigate genetic variants, EWAS emphasizes the role of environmental factors and lifestyle choices on gene regulation, providing insights into how epigenetic changes can influence health and disease over time. The findings from EWAS can potentially lead to novel biomarkers for disease diagnosis and new therapeutic targets by highlighting critical epigenetic alterations involved in disease mechanisms.
Start your personalized study experience with acemate today. Sign up for free and find summaries and mock exams for your university.